All Stories

  1. Assessing microbiota in vivo: debugging with medical imaging
  2. TSST-1 promotes colonization of Staphylococcus aureus within the vaginal tract by activation of CD8 + T cells
  3. TSST-1 promotes colonization ofStaphylococcus aureuswithin the vaginal tract by activation of CD8+T cells
  4. Bacterial association with metals enables in vivo monitoring of urogenital microbiota using magnetic resonance imaging
  5. Interconnected microbiomes—insights and innovations in female urogenital health
  6. Magnetic Resonance Imaging of Bacteria: In Vitro Characterization of Lactobacillus Crispatus ATCC33820 at 3T
  7. Predictive Modeling of Urinary Stone Composition Using Machine Learning and Clinical Data: Implications for Treatment Strategies and Pathophysiological Insights
  8. Ethanolamine enhances adhesion, promotes microcompartment formation, and modulates gene expression in Levilactobacillus brevis ATCC 14869
  9. The Microbial Revolution in the World of Joint Replacement Surgery
  10. Predispose, precipitate, perpetuate, and protect: how diet and the gut influence mental health in emerging adulthood
  11. Science around the world
  12. Dissecting mechanisms of fecal microbiota transplantation efficacy in disease
  13. Bacterial association with metals enables in vivo monitoring of microbiota using magnetic resonance imaging
  14. Multi-site microbiota alteration is a hallmark of kidney stone formation
  15. Author Correction: Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
  16. In focus: perplexing increase of urinary stone disease in children, adolescent and young adult women and its economic impact
  17. Assessing the impact of pregnancy and birth factors on the maternal and infant microbiota
  18. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
  19. Delivery mechanism can enhance probiotic activity against honey bee pathogens
  20. Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome
  21. Supplementing Yogurt with Probiotic Bifidobacteria to Counter Chronic Kidney Disease
  22. The Role of Microbiota-Derived Vitamins in Immune Homeostasis and Enhancing Cancer Immunotherapy
  23. The Role of Urinary Modulators in the Development of Infectious Kidney Stones
  24. Osteopontin phosphopeptide mitigates calcium oxalate stone formation in a Drosophila melanogaster model
  25. New perspectives on an old grouping: The genomic and phenotypic variability of Oxalobacter formigenes and the implications for calcium oxalate stone prevention
  26. Improved MAIT cell functions following fecal microbiota transplantation for metastatic renal cell carcinoma
  27. Probiotic Bifidobacteria Mitigate the Deleterious Effects of para -Cresol in a Drosophila melanogaster Toxicity Model
  28. Long-Duration Space Travel Support Must Consider Wider Influences to Conserve Microbiota Composition and Function
  29. Drugs, Guts, Brains, but Not Rock and Roll: The Need to Consider the Role of Gut Microbiota in Contemporary Mental Health and Wellness of Emerging Adults
  30. Bacterial association with metals enables in vivo tracking of microbiota using magnetic resonance imaging
  31. Effectiveness of the Lorodent Probiotic Lozenge in Reducing Plaque and Streptococcus mutans Levels in Orthodontic Patients: A Double-Blind Randomized Control Trial
  32. Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: A pilot randomized controlled trial
  33. Safety assessment of Streptococcus salivarius M18 a probiotic for oral health
  34. Why Are Bifidobacteria Important for Infants?
  35. High-Throughput in vitro Gel-Based Plate Assay to Screen for Calcium Oxalate Stone Inhibitors
  36. Emerging connections between gut microbiome bioenergetics and chronic metabolic diseases
  37. The Two-Way Interaction between the Molecules That Cause Vaginal Malodour and Lactobacilli: An Opportunity for Probiotics
  38. Deciphering the low abundance microbiota of presumed aseptic hip and knee implants
  39. Interstrain Variability of Human Vaginal Lactobacillus crispatus for Metabolism of Biogenic Amines and Antimicrobial Activity against Urogenital Pathogens
  40. Meta-analysis on the effect of bacterial interventions on honey bee productivity and the treatment of infection
  41. Fosfowash: Early proof of concept study investigating intravesical fosfomycin for recurrent urinary tract infections
  42. Processing human urine and ureteral stents for 16S rRNA amplicon sequencing
  43. Streptococcus salivarius inhibits immune activation by periodontal disease pathogens
  44. Response to Ianiro et al.
  45. Evaluation of Polyethylene Glycol-Based Antimicrobial Coatings on Urinary Catheters in the Prevention ofEscherichia coliInfections in a Rabbit Model
  46. Young scientist perspective—microbiology trainees and social media: making science go viral during a pandemic
  47. Author Correction: Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients
  48. Immunomodulation in Pancreatic Cancer
  49. Oxalate-Degrading Bacillus subtilis Mitigates Urolithiasis in a Drosophila melanogaster Model
  50. Lactobacillus spp. attenuate antibiotic-induced immune and microbiota dysregulation in honey bees
  51. Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients
  52. Expired probiotics: what is really in your cabinet?
  53. Issues beyond resistance: inadequate antibiotic therapy and bacterial hypervirulence
  54. Ureteral Stent Microbiota Is Associated with Patient Comorbidities but Not Antibiotic Exposure
  55. Expired Probiotics: What is Really in Your Cabinet?
  56. Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial
  57. Nutritional, Microbial, and Allergenic Changes during the Fermentation of Cashew ‘Cheese’ Product Using a Quinoa-Based Rejuvelac Starter Culture
  58. Current update and future directions on gut microbiome and nephrolithiasis
  59. Potential Role of Extracellular ATP Released by Bacteria in Bladder Infection and Contractility
  60. Novel probiotic approach to counter Paenibacillus larvae infection in honey bees
  61. Deleterious Effects of Neonicotinoid Pesticides on Drosophila melanogaster Immune Pathways
  62. Ibuprofen lacks direct antimicrobial properties for the treatment of urinary tract infection isolates
  63. Response to Long et al regarding: “Cutibacterium acnes and the shoulder microbiome”
  64. Application of Novel 3,4-Dihydroxyphenylalanine-Containing Antimicrobial Polymers for the Prevention of Uropathogen Attachment to Urinary Biomaterials
  65. International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis
  66. The Microbiome and Genitourinary Cancer: A Collaborative Review
  67. Potential role of extracellular ATP released by bacteria in bladder infection and contractility
  68. The Impact of Uremia and Intestinal Dysbiosis on Hepatic Drug Metabolism in a Rat Model of Progressive Chronic Kidney Disease
  69. Immobilization of cadmium and lead by Lactobacillus rhamnosus GR-1 mitigates apical-to-basolateral heavy metal translocation in a Caco-2 model of the intestinal epithelium
  70. Drosophila melanogaster as a function-based high-throughput screening model for antinephrolithiasis agents in kidney stone patients
  71. Cutibacterium acnes and the shoulder microbiome
  72. Moving on from Metchnikoff: thinking about microbiome therapeutics in cancer
  73. Enterococcus faecalis persistence in pediatric patients treated with antibiotic prophylaxis for recurrent urinary tract infections
  74. Inflatable Penile Prostheses Implantation: Does Antibiotic Exposure Matter?
  75. Daily therapy with a slow-releasing H 2 S donor GYY4137 enables early functional recovery and ameliorates renal injury associated with urinary obstruction
  76. Microbiome
  77. Evaluation of sampling and storage procedures on preserving the community structure of stool microbiota: A simple at-home toilet-paper collection method
  78. Transfer of altered behaviour and irritable bowel syndrome with diarrhea (IBS-D) through fecal microbiota transplant in mouse model indicates need for stricter donor screening criteria
  79. Using the Human Gastrointestinal Microbiome to Personalize Nutrition Advice: Are Registered Dietitian Nutritionists Ready for the Opportunities and Challenges?
  80. Super healthy elderly chinese have a 'young' microbiota
  81. Faecal microbiota transplantation: Where did it start? What have studies taught us? Where is it going?
  82. Lactobacillus rhamnosus GR-1 Attenuates Induction of Hypertrophy in Cardiomyocytes but Not through Secreted Protein MSP-1 (p75)
  83. Impact of birth weight and postnatal diet on the gut microbiota of young adult guinea pigs
  84. Impact of birth weight and postnatal diet on the gut microbiota of young adult guinea pigs
  85. Impact of birth weight and postnatal diet on the gut microbiota of young adult guinea pigs
  86. Use of Bacillus in Human Intestinal Probiotic Applications
  87. Extended Screening Costs Associated With Selecting Donors for Fecal Microbiota Transplantation for Treatment of Metabolic Syndrome-Associated Diseases
  88. Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs
  89. Questions and challenges associated with studying the microbiome of the urinary tract
  90. Making sense of the urinary microbiota in clinical urology
  91. Efficacy of Probiotic Therapy in Preventing Overt Hepatic Encephalopathy
  92. The oral microbiome of patients with axial spondyloarthritis compared to healthy individuals
  93. Inhibition of Candida albicans biofilm formation and modulation of gene expression by probiotic cells and supernatant
  94. Pathogenic Mechanisms of Uropathogens
  95. Probiotic lactobacilli: a potential prophylactic treatment for reducing pesticide absorption in humans and wildlife
  96. Mycobacterium tuberculosis PE25/PPE41 protein complex induces activation and maturation of dendritic cells and drives Th2-biased immune responses
  97. Microbiota at Multiple Body Sites during Pregnancy in a Rural Tanzanian Population and Effects of Moringa-Supplemented Probiotic Yogurt
  98. Subinhibitory Antibiotic Therapy Alters Recurrent Urinary Tract Infection Pathogenesis through Modulation of Bacterial Virulence and Host Immunity
  99. The microbiome of the urinary tract—a role beyond infection
  100. Inclusion of Fermented Foods in Food Guides around the World
  101. The influence of the human microbiome and probiotics on cardiovascular health
  102. Randomized Open-Label Pilot Study of the Influence of Probiotics and the Gut Microbiome on Toxic Metal Levels in Tanzanian Pregnant Women and School Children
  103. Microbes Central to Human Reproduction
  104. A Systems Biology Approach Investigating the Effect of Probiotics on the Vaginal Microbiome and Host Responses in a Double Blind, Placebo-Controlled Clinical Trial of Post-Menopausal Women
  105. Endogenous biotin expression in renal and testicular tumors and literature review
  106. Effect of chemotherapy on the microbiota and metabolome of human milk, a case report
  107. Probiotic Administration Attenuates Myocardial Hypertrophy and Heart Failure After Myocardial Infarction in the Rat
  108. Streptococci as Effector Organisms for Probiotic and Replacement Therapy
  109. Microbiota of Human Breast Tissue
  110. Selective Target Inactivation Rather than Global Metabolic Dormancy Causes Antibiotic Tolerance in Uropathogens
  111. High throughput sequencing methods and analysis for microbiome research
  112. Adhesion of Lactobacillus iners AB-1 to Human Fibronectin: A Key Mediator for Persistence in the Vagina?
  113. Persistence of the Oral Probiotic Streptococcus salivarius M18 Is Dose Dependent and Megaplasmid Transfer Can Augment Their Bacteriocin Production and Adhesion Characteristics
  114. Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebo-controlled trial
  115. If microbial ecosystem therapy can change your life, what's the problem?
  116. Probiotics and nutrients for the first 1000 days of life in the developing world
  117. The Rationale for Probiotics Improving Reproductive Health and Pregnancy Outcome
  118. The Role of the Microbiome in Rheumatic Diseases
  119. Influence of the Vaginal Microbiota on Toxic Shock Syndrome Toxin 1 Production by Staphylococcus aureus
  120. Bioremediation and Tolerance of Humans to Heavy Metals through Microbial Processes: a Potential Role for Probiotics?
  121. Breast, Milk and Microbes: A Complex Relationship that Does Not End with Lactation
  122. Amplification of Oral Streptococcal DNA from Human Incisors and Bite Marks
  123. Effect of Streptococcus salivarius K12 on the In Vitro Growth of Candida albicans and Its Protective Effect in an Oral Candidiasis Model
  124. Salivaricin G32, a Homolog of the PrototypeStreptococcus pyogenesNisin-Like Lantibiotic SA-FF22, Produced by the Commensal SpeciesStreptococcus salivarius
  125. Streptococcus
  126. Genome Sequence of the Bacteriocin-Producing Oral Probiotic Streptococcus salivarius Strain M18
  127. Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: A randomized, placebo-controlled, double-blind study
  128. Beneficial microbes for the oral cavity: time to harness the oral streptococci?
  129. Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius
  130. Probiotic Therapy for the Treatment of Spondyloarthritis: A Randomized Controlled Trial
  131. Is there a correlation between bacterial vaginosis and preterm labour in women in the Otago region of New Zealand?
  132. Extended Safety Data for the Oral Cavity Probiotic Streptococcus salivarius K12
  133. Something Old and Something New: An Update on the Amazing Repertoire of Bacteriocins Produced by Streptococcus salivarius
  134. Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics
  135. Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12
  136. A species-specific PCR forLactobacillus inersdemonstrates a relative specificity of this species for vaginal colonization
  137. Quantitative determination by real-time PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae indicates an inverse relationship between L. gasseri and L. iners
  138. Salivaricin A2 and the Novel Lantibiotic Salivaricin B Are Encoded at Adjacent Loci on a 190-Kilobase Transmissible Megaplasmid in the Oral Probiotic Strain Streptococcus salivarius K12
  139. Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius
  140. Safety Assessment of the Oral Cavity Probiotic Streptococcus salivarius K12
  141. PCR-DGGE analysis of aspirates from chronic rhinosinusitis patients
  142. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters
  143. Oral streptococcal BLIS: Heterogeneity of the effector molecules and potential role in the prevention of streptococcal infections
  144. Non-Culture-Based Analysis of Bacterial Populations from Patients with Chronic Rhinosinusitis
  145. A preliminary survey of Atopobium vaginae in women attending the Dunedin gynaecology out‐patients clinic: Is the contribution of the hard‐to‐culture microbiota overlooked in gynaecological disorders?
  146. O17 Effect of Probiotic Streptococcus salivarius K12 on oral malodour parameters
  147. The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics
  148. Novel insight into the vaginal microflora in postmenopausal women under hormone replacement therapy as analyzed by PCR-denaturing gradient gel electrophoresis
  149. Nucleic Acid-Based Diagnosis of Bacterial Vaginosis and Improved Management Using Probiotic Lactobacilli
  150. Detection of Atopobium vaginae in Postmenopausal Women by Cultivation-Independent Methods Warrants Further Investigation
  151. Surface‐enhanced laser desorption/ionization‐time of flight‐mass spectrometry (SELDI‐TOF‐MS): A new proteomic urinary test for patients with urolithiasis
  152. Atomic force microscopic and encrustation studies of novel prospective polyisobutylene‐based thermoplastic elastomeric biomaterials
  153. Evaluation of QIAamp® DNA Stool Mini Kit for ecological studies of gut microbiota
  154. Oxalate-Degrading Enzymes fromOxalobacter formigenes: A Novel Device Coating to Reduce Urinary Tract Biomaterial-Related Encrustation
  155. Detection of Bifidobacterium species and Gardnerella vaginalis in the vagina using PCR and denaturing gradient gel electrophoresis (DGGE)
  156. Digoxigenin-labelled peptide nucleic acid to detect lactobacilli PCR amplicons immobilized on membranes from denaturing gradient gel electrophoresis
  157. Improved Understanding of the Bacterial Vaginal Microbiota of Women before and after Probiotic Instillation
  158. Evaluation of the Bacterial Vaginal Flora of 20 Postmenopausal Women by Direct (Nugent Score) and Molecular (Polymerase Chain Reaction and Denaturing Gradient Gel Electrophoresis) Techniques
  159. Identification, Detection, and Enumeration of Human Bifidobacterium Species by PCR Targeting the Transaldolase Gene
  160. Lactobacillus Strains and Vaginal Ecology
  161. Use of Lactobacillus to prevent infection by pathogenic bacteria
  162. Properties of Porcine and Yogurt Lactobacilli in Relation to Lactose Intolerance